Daniel Davis

Daniel Davis joined Imperative Care in 2020 and brings 19 years of experience in sales, marketing, and business development with both early stage and Fortune 500 companies in medical devices and before that in software and consumer products. Prior to Imperative Care, he was Chief Commercial Officer and President, North America for Penumbra, Inc. where he helped lead the company’s IPO and successful entry into the peripheral vascular market. Daniel earned increasing responsibility in the company as he progressed from a leader in the marketing organization to Vice President of Strategy to President, North America. Joining Penumbra in 2007 in the pre-commercial phase, Daniel launched the first FDA cleared intracranial delivery catheter (Neuron), the first FDA cleared aspiration system for neurovascular mechanical thrombectomy (Penumbra System), and the Penumbra Coil 400 for the treatment of intracranial aneurysms. Previously, he held sales and marketing positions of increasing responsibility at Boston Scientific (now Stryker Neurovascular) as well as roles at Newell Rubbermaid and Trilogy. Daniel holds an A.B. in History and in Economics from Duke University.